National Vaccine
Information Center

Your Health. Your Family. Your Choice.
MedAlerts Home
  Read the MedAlerts Blog Subscribe to the MedAlerts Blog 

Found 593491 cases in entire database

Case Details

This is page 20830 out of 29675

Result pages: prev   20811 20812 20813 20814 20815 20816 20817 20818 20819 20820 20821 20822 20823 20824 20825 20826 20827 20828 20829 20830 20831 20832 20833 20834 20835 20836 20837 20838 20839 20840 20841 20842 20843 20844 20845 20846 20847 20848 20849   next


VAERS ID:478819 (history)  Vaccinated:2012-10-29
Age:  Onset:2012-10-29, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 31
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011254
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 29-OCT-2012 22:18, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478820 (history)  Vaccinated:2012-10-07
Age:  Onset:2012-10-07, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 53
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011096
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 07-OCT-2012 00:33, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. the outcome of the event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478821 (history)  Vaccinated:2012-12-05
Age:61.0  Onset:2012-12-06, Days after vaccination: 1
Gender:Female  Submitted:2012-12-09, Days after onset: 3
Location:Connecticut  Entered:2012-12-19, Days after submission: 10
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Seasonal hay fever; Morphine type product
Diagnostic Lab Data:
CDC Split Type:
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.H0130240SCLA
Administered by: Other     Purchased by: Private
Symptoms: Cellulitis, Local reaction, Skin warm, Swelling
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Write-up: Thurs noticed large localized reaction, heat, swelling larger than silver dollar, Friday symptoms then intensified, saw dr on Saturday, he prescribed antibiotic which patient started, cellulitis diagnosed.

VAERS ID:478822 (history)  Vaccinated:2012-10-06
Age:  Onset:2012-10-06, Days after vaccination: 0
Gender:Female  Submitted:2012-11-29, Days after onset: 54
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011095
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 06-OCT-2012 21:40, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During the 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0395AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478823 (history)  Vaccinated:2012-10-27
Age:  Onset:2012-10-27, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 33
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medication
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011247
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 27-OCT-2012 18:58, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478824 (history)  Vaccinated:2012-10-15
Age:  Onset:2012-10-15, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 45
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011144
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn (male) patient of unknown age. On 15-OCT-2012 13:08, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478825 (history)  Vaccinated:2012-10-30
Age:  Onset:2012-10-30, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 30
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011256
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 30-OCT-2012 10:27, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478826 (history)  Vaccinated:2012-10-31
Age:  Onset:2012-10-31, Days after vaccination: 0
Gender:Female  Submitted:2012-11-29, Days after onset: 29
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011260
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 31-OCT-2012 10:53, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478827 (history)  Vaccinated:2012-10-29
Age:  Onset:2012-10-29, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 31
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011252
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 29-OCT-2012 14:46, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478828 (history)  Vaccinated:2012-10-27
Age:75.0  Onset:2012-10-27, Days after vaccination: 0
Gender:Male  Submitted:2012-12-19, Days after onset: 53
Location:Foreign  Entered:2012-12-20, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
    Extended hospital stay? No
Previous Vaccinations:
Other Medications: ADCAL; Bisoprolol; Lactulose; Miconazole; Omeprazole; Prednisolone; Tamsulosin hydrochloride
Current Illness: Atrial fibrillation; Benign prostatic hyperplasia; Idiopathic thrombocytopenic purpura; Rheumatoid arthritis; Tricuspid valve incompetence
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: PHFR2012GB006429
Vaccination
Manufacturer
Lot
Dose
Route
Site
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME)UNKNOWN MANUFACTURER  SYRUN
Administered by: Other     Purchased by: Other
Symptoms: Haematuria, Muscular weakness, Platelet count decreased, Urinary tract infection
SMQs:, Rhabdomyolysis/myopathy (broad), Haematopoietic thrombocytopenia (narrow), Peripheral neuropathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Tubulointerstitial diseases (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)
Write-up: Case number PHFR2012GB006429 is an initial spontaneous report from a physician via health authority (reference number 21941062) received on 13 Dec 2012. This report refers to a 75-year-old male patient. The patient''s medical history included atrial fibrillation, benign prostatic hyperplasia, idiopathic thrombocytopenic purpura, rheumatoid arthritis and tricuspid insufficiency. Concomitant medications included ADCAL, bisoprolol, lactulose, miconazole, omeprazole, prednisolone tamsulosin hydrochloride and Warfarin sodium. He was vaccinated with influenza virus vaccine (manufacturer, batch number not specified) on 27 Oct 2012. He was vaccinated in the morning and that afternoon after vaccination he had profound weakness in upper and lower limbs such that he had to crawl to get upstairs to bed. He remained very weak over next few days and was confined to bed initially. He was just able to mobilized a short distance. He was seen by his physician and was admitted to a hospital. There was a gradual improvement in his muscle power over last few weeks. On admission, hematuria with urinary tract infection and low platelet count were observed. The outcome of the event weakness in upper and lower limbs was reported as recovering/resolving and the outcome of remaining events was unknown. The event weakness in upper and lower limbs was reported as serious (hospitalization) and remaining events as medically significant. The causality assessment of the events was not reported.

VAERS ID:478829 (history)  Vaccinated:2012-10-31
Age:  Onset:2012-10-31, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 29
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011259
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 31-OCT-2012 09:33, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478831 (history)  Vaccinated:2012-10-16
Age:  Onset:2012-10-16, Days after vaccination: 0
Gender:Female  Submitted:2012-11-29, Days after onset: 44
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011146
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn (female) patient of unknown age. On 16-OCT-2012 09:48, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478832 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Unknown  Submitted:2012-11-29
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Chronic obstructive pulmonary disease
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA010904
Vaccination
Manufacturer
Lot
Dose
Route
Site
PPV: PNEUMO (PNEUMOVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect dose administered
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to unspecified number of patients. The pharmacist reported that she had some patients with certain condition, like COPD, who received PNEUMOVAX23 (lot number, dose, route and injection site were not reported) every year. No other co-suspects were reported. No concomitant medications were reported. Specific number of patients unknown. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478833 (history)  Vaccinated:2012-10-27
Age:  Onset:2012-10-27, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 33
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011246
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 27-OCT-2012 18:26, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478834 (history)  Vaccinated:0000-00-00
Age:69.0  Onset:0000-00-00
Gender:Male  Submitted:2012-11-29
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Amoxicillin
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA009918
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Injection site rash, Rash, Vaccination site rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)
Write-up: This spontaneous report as received from a Pharmacist refers to a 69 years old male patient. The patient was vaccinated with ZOSTAVAX (dose, route and lot # were unknown) an unspecified date. No other co-suspects were reported. Concomitant medications included: AMOXICILLIN. On an unknown date the patient developed a rash at the injection site of the ZOSTAVAX. The pharmacist indicated that on an unspecified date the rash resolved. The pharmacist indicated the patient had another rash appear on the side of the neck that did not resolve. The patient sought medical attention at their doctor''s office and saw a nurse. It was indicated by the nurse that it wasn''t believed to be caused by the ZOSTAVAX. The pharmacist described the adverse effect as an alligator like crust which subsided in the evening but flared during the daytime and worsened when hot water was applied. Additional information is not expected.

VAERS ID:478835 (history)  Vaccinated:2012-10-28
Age:  Onset:2012-10-28, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 32
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011249
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 28-OCT-2012 10:40, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478836 (history)  Vaccinated:2012-10-27
Age:  Onset:2012-10-27, Days after vaccination: 0
Gender:Female  Submitted:2012-11-29, Days after onset: 33
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011243
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385E UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 27-OCT-2012 12:24, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified with lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478837 (history)  Vaccinated:2012-10-28
Age:  Onset:2012-10-28, Days after vaccination: 0
Gender:Female  Submitted:2012-11-29, Days after onset: 32
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011248
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 28-OCT-2012 03:47, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478838 (history)  Vaccinated:2012-10-29
Age:  Onset:2012-10-29, Days after vaccination: 0
Gender:Male  Submitted:2012-11-29, Days after onset: 31
Location:Unknown  Entered:2012-11-29
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011250
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 29-OCT-2012 02:30, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

VAERS ID:478839 (history)  Vaccinated:2012-10-29
Age:  Onset:2012-10-29, Days after vaccination: 0
Gender:Female  Submitted:2012-11-20, Days after onset: 22
Location:Unknown  Entered:2012-11-29, Days after submission: 9
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: WAES1211USA011251
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEP: HEP B (RECOMBIVAX HB)MERCK & CO. INC.0385AE UNUN
Administered by: Other     Purchased by: Other
Symptoms: Incorrect storage of drug
SMQs:, Medication errors (narrow)
Write-up: This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 29-OCT-2012 14:19, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.

Result pages: prev   20811 20812 20813 20814 20815 20816 20817 20818 20819 20820 20821 20822 20823 20824 20825 20826 20827 20828 20829 20830 20831 20832 20833 20834 20835 20836 20837 20838 20839 20840 20841 20842 20843 20844 20845 20846 20847 20848 20849   next

New Search

Link To This Search Result:
http://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=20830&PERPAGE=20&ESORT=ENTRY.


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166